Genetic
Pharmacogenomics
Pharmacogenomics is a genetic therapy with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
GENETIC
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution2 total trials
Phase 4Post-market surveillance
2(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Other(2)
Detailed Status
unknown2
Completed1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 42 (100.0%)
Trials by Status
unknown250%
completed125%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
unknown
Precision Medicine Platform for Novel Oral Anticoagulants
NCT04056143
unknownphase_4
Accurate Clinical Study of Medication in Patients With Depression Via Pharmacogenomics (PGx) and Therapeutic Drug Monitoring (TDM) of Venlafaxine
NCT04207385
recruitingphase_4
ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)
NCT02670564
completed
Pharmacogenomics and Effective Treatment With Clopidogrel
NCT01611545
Clinical Trials (4)
Showing 4 of 4 trials
NCT04056143
Precision Medicine Platform for Novel Oral Anticoagulants
NCT04207385Phase 4
Accurate Clinical Study of Medication in Patients With Depression Via Pharmacogenomics (PGx) and Therapeutic Drug Monitoring (TDM) of Venlafaxine
NCT02670564Phase 4
ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)
NCT01611545
Pharmacogenomics and Effective Treatment With Clopidogrel
All 4 trials loaded
Drug Details
- Intervention Type
- GENETIC
- Total Trials
- 4